Comparison of Re-vitrectomy Rates in TAP and INJECT versus Pars Plana Vitrectomy for Acute Endophthalmitis: A Retrospective Comparative Study

Main Article Content

Jedsada Buathong
Piboon Bavornvattanadilok
Kittichai Akrapipatkul
Navapol Kanchanaranya
Theinchai Pasurakul
Lisa Kongrat
Nattapon Wongcumchang

บทคัดย่อ

Background: Acute endophthalmitis is a severe complication of ocular surgery requiring prompt treatment to prevent vision loss. The optimal initial treatment—vitreous tapping with intravitreal injection (TAP) versus pars plana vitrectomy (PPV)—remains debated. Advances in vitrectomy techniques challenge conclusions from the Endophthalmitis Vitrectomy Study (EVS), prompting this study to compare re-vitrectomy rates and outcomes between TAP and PPV.
Methods: This retrospective study analyzed 34 patients diagnosed with acute endophthalmitis at a tertiary care center. Patients were divided into TAP (Group 1, n = 10) and PPV (Group 2, n = 24) groups. Demographic data, clinical presentations, microbial culture results, and outcomes—including visual acuity (VA) improvement and re-vitrectomy rates—were compared using statistical analyses. A subgroup analysis focused on patients with presenting VA ≥ hand motion.
Results: Group 1 (TAP) had a significantly higher re-vitrectomy rate (50% vs. 16.7%, p = 0.044) despite comparable VA improvement between groups (50% vs. 45.8%, p = 0.618). In the subgroup with VA ≥ hand motion, re-vitrectomy rates were higher in Group 1 (44.4% vs. 9.5%, p = 0.028), while VA improvement was similar (62.5% vs. 52.4%, p = 0.62). Positive microbial cultures were exclusive to Group 2 (29.1%).
Conclusion: TAP and PPV yield comparable VA improvement, but PPV significantly reduces the need for re-vitrectomy, highlighting the advantages of modern surgical techniques. Further research is needed to refine treatment protocols.

Article Details

ประเภทบทความ
Original Study

เอกสารอ้างอิง

Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol. 2005;123(5):613–20.

Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Corey RP, Miller D. Endophthalmitis caused by streptococcal species: Clinical settings, microbiology, management, and outcomes. Am J Ophthalmol. 2004;138(6):982–7.

Pijl BJ, Theelen T, Tilanus MA, Rentenaar RJ, Liem AT. Infectious endophthalmitis: Diagnosis and management. Int Ophthalmol. 2017;37(3):433–44.

Doft BH, Barza M, Sutter FK, Wisniewski SR. Optimal management of acute postcataract extraction endophthalmitis: The Endophthalmitis Vitrectomy Study approach. Surv Ophthalmol. 1997;41(5):387–98.

Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479–96.

Kuhn F, Gini G. Ten years after… Are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005;243(12):1197–9.

Gupta B, Chhablani J, Rani PK, et al. Endophthalmitis: Current practices in management and the role of vitrectomy. Indian J Ophthalmol. 2014;62(3):275–87.

Tan CS, Wong HK, Yang FP, Lee JJ. Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis. Eye (Lond). 2008;22(1):150–1.

Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology. 2010;117(1):93–102.e2.

Rizzo S, Barca F, Caporossi T, Mariotti C. Twenty-seven-gauge vitrectomy for various vitreoretinal diseases: Surgical and functional outcomes. Graefes Arch Clin Exp Ophthalmol. 2014;252(8):1411–8.

Narang P, Agarwal A, Narang S. Role of intraoperative optical coherence tomography in vitreoretinal surgery. Indian J Ophthalmol. 2021;69(5):1045–57.

Ho IV, Fernandez-Sanz G, Levasseur S, et al. Early Pars Plana Vitrectomy for Treatment of Acute Infective Endophthalmitis. Asia Pac J Ophthalmol (Phila). 2019;8(1):3–7.

Kuhn F, Morris R, Witherspoon CD, Mester V. Infectious endophthalmitis: New perspectives in vitreoretinal surgery. Ophthalmol Clin N Am. 2001;14(4):521–30.

Dib B, Morris RE, et al. Complete and Early Vitrectomy for Endophthalmitis After Cataract Surgery: An Alternative Treatment Paradigm. Clin Ophthalmol. 2020;14:1945–54.

Tabatabaei SA, Aminzade S, Ahmadraji A, et al. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; A quasi-experimental study. BMC Ophthalmol. 2022;22(1):16.

Far PM, Yeung SC, Farimani PL, et al. TAP AND INJECT VERSUS PARS PLANA VITRECTOMY FOR POSTPROCEDURAL ENDOPHTHALMITIS: A Meta-analysis. Retina. 2021;41(10):2009–16.

Clarke B, Williamson TH, Gini G, Gupta B. Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Surv Ophthalmol. 2018;63(5):677–93.

Sen P, Agarwal K, Bhende P. Advances in the management of infectious endophthalmitis. Indian J Ophthalmol. 2021;69(11):3130–43.

Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227–34.

Becker M, Zegarra H, Vargas JM. Current trends in endophthalmitis management: A literature review. Int Ophthalmol Clin. 2022;62(2):223–42.